Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Restructuring Costs: 2009-2020

Historic Restructuring Costs for Ironwood Pharmaceuticals (IRWD) over the last 4 years, with Dec 2020 value amounting to $15.4 million.

  • Ironwood Pharmaceuticals' Restructuring Costs fell 105.93% to -$73,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 million, marking a year-over-year decrease of 22.05%. This contributed to the annual value of $15.4 million for FY2020, which is 325.41% up from last year.
  • As of FY2020, Ironwood Pharmaceuticals' Restructuring Costs stood at $15.4 million, which was up 325.41% from $3.6 million recorded in FY2019.
  • In the past 5 years, Ironwood Pharmaceuticals' Restructuring Costs ranged from a high of $15.4 million in FY2020 and a low of $3.6 million during FY2019.
  • Its 3-year average for Restructuring Costs is $11.2 million, with a median of $14.7 million in 2018.
  • In the last 5 years, Ironwood Pharmaceuticals' Restructuring Costs crashed by 75.40% in 2019 and then surged by 325.41% in 2020.
  • Over the past 3 years, Ironwood Pharmaceuticals' Restructuring Costs (Yearly) stood at $14.7 million in 2018, then tumbled by 75.40% to $3.6 million in 2019, then surged by 325.41% to $15.4 million in 2020.